Teva Pharmaceuticals @TevaUSA
Can a focus on biosimilars drive innovation and expand access to much-needed treatments? Teva’s SVP Specialty Sales and Marketing Tom Rainey discusses the hidden value of #biosimilars. @statnews https://t.co/5M7E9Yy2ug https://t.co/oh1fn5v8RU — PolitiTweet.org